In continued efforts to secure a greener future in the battery metals industry, Technology Minerals is pleased to welcome Nick Elmslie as an Advisor to the Board.
Elmslie has extensive experience in the chemicals industry. His financial expertise will offer a unique opinion to allow better decision making for Technology Minerals, which has just signed a deal with UK lead-acid battery recycling group, Recyclus.
Technology Minerals is determined to secure a greener future for the battery industry, and this latest appointment will contribute towards a more sustainable future.
Nick Elmslie spoke of his excitement regarding the role:
“This is a really exciting time to be helping Technology Minerals. The plans to make the sourcing and recycling of batteries more sustainable is exciting and I can’t wait to offer my opinion and get involved where I can. The battery sector is overdue a shift in mentality because the majority of parts initially went to landfill, which has had a detrimental impact on the environment.”
Alex Stansbury, CEO of Technology Minerals commented: “Nick is a very highly skilled professional and we are delighted to welcome him as an Advisor to the Board. We have massive plans for the sector and with Nick’s experience and unique opinion, we will be able to achieve much more.”
Technology Minerals will be publicly listed on the London Stock Exchange, in March 2021, via a Reverse Takeover (RTO) with Stranger Holdings Plc (to be renamed Technology Minerals PLC upon completion of the RTO).
Name - Technology Minerals
E-mail - [email protected]
Phone no - 0203 432 3080
Company - Technology Minerals
Country - United Kingdom
Address - 18 Savile Row, London, W1S 3PW UK
The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.
Release ID: 17490